The SPEEDCELL project is a four-year EU-cofunded initiative led by HIPRA
The initiative focuses on optimizing development and manufacturing processes based on cell lines, widely used in the production of vaccines and biological products.
CHALLENGES
Reducing the
time-to-market
Manufacturing
infrastructure
Production
scalability
Europe’s strategic
autonomy
MISSION
SPEEDCELL’s mission is to boost Europe’s ability to respond to health emergencies by streamlining cell line development and manufacturing.
News
Suscribe to our newsletter
for all the latest news
Accelerate the development and production of biologics
Cofunded by the European Union under grant agreement No 101136439. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union (EU) or European Health and Digital Executive Agency (HaDEA). Neither the EU nor HaDEA can be held responsible for them.